{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0002-1717",
      "generic_name": "imlunestrant",
      "labeler_name": "Eli Lilly and Company",
      "brand_name": "Inluriyo",
      "active_ingredients": [
        {
          "name": "IMLUNESTRANT",
          "strength": "200 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0002-1717-28",
          "description": "28 TABLET, FILM COATED in 1 BOTTLE (0002-1717-28)",
          "marketing_start_date": "20251016",
          "sample": false
        },
        {
          "package_ndc": "0002-1717-56",
          "description": "56 TABLET, FILM COATED in 1 BOTTLE (0002-1717-56)",
          "marketing_start_date": "20251015",
          "sample": false
        },
        {
          "package_ndc": "0002-1717-61",
          "description": "56 TABLET, FILM COATED in 1 BOTTLE (0002-1717-61)",
          "marketing_start_date": "20251113",
          "sample": true
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "0f64afa6-a367-4dfe-a0ca-8631aa894f61",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20250925",
      "product_id": "0002-1717_0f64afa6-a367-4dfe-a0ca-8631aa894f61",
      "application_number": "NDA218881",
      "brand_name_base": "Inluriyo",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Estrogen Receptor Antagonist [EPC]",
        "Estrogen Receptor Antagonists [MoA]",
        "P-Glycoprotein Inhibitors [MoA]"
      ]
    }
  ]
}